SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

update - GVK is 'respectful' of EMA recommendation and is working with customers

EMA recommends suspending 100s of drugs tested by GVK at Hyderabad site

The EMA has called for the suspension or withdrawal of 700 medicines whose approval was based on testing by Indian CRO GVK Biosciences.

EMA recommeds suspending GVK

Covance's LabCorp distraction will drive opportunities for CRL, says analyst

Investment firm William Blair has upgraded preclinical CRO Charles River Laboratories to ‘outperform’ based on strong toxicology demand and the pending acquisition of Covance.

CRO Simbec-Orion lands Phase III lupus trial with fast-tracked compound

ImmuPharma and the recently formed CRO Simbec-Orion Group have entered into a collaboration to run a Phase III clinical study of the potential lupus treatment Lupuzor. Financial terms of the agreement were not released.

PCI company expands temp-controlled trial supply services

Biotec Services International, daughter company of clinical trial suppliers Packaging Coordinators Inc (PCI), has expanded its cold-chain storage and distribution capacity in response to client demand for a “one-stop shop”.

Lonza benefits from outsourcing growth as Swiss franc fluctuations stall 2015 projections

Biopharma outsourcing growth has helped to boost the bottom line of Lonza, the world’s largest manufacturer of drug ingredients, though a topsy-turvy Swiss franc has caused the company to hold off on making any projections for 2015.

Spotlight

Could one-stop-shop CMOs fall into pharma's over-capacity curse?

One-stop-shop CMOs could fall into pharma's over-capacity curse, say experts

CMO consolidation is resurrecting the ‘all-under-one-roof’ manufacturing model, but will firms fall into the same inefficiency pitfalls...

Charles River considers re-opening preclinical site in Mass.

Charles River considers re-opening preclinical site in Massachusetts

CRO Charles River Laboratories (CRL) may re-open a preclinical site in Shrewsbury, MA, if demand for the...

Parexel strong book-to-bill 'reassuring' for CRO demand, says analyst

Parexel strong book-to-bill 'reassuring' for CRO demand, says analyst

Parexel’s improved book-to-bill ratio is a reassuring sign for the company and the CRO industry as a whole,...

Crown expands Precos site to build caucasian cancer expertise

Crown expands Precos site to build caucasian cancer expertise

Crown Biosciences has announced plans to double capacity at a site operated by its Precos division.

Oil slump good for API makers, until a major supplier turns off the tap says industry group

Oil slump good for API makers, until a major supplier turns off the tap says industry group

Falling oil prices are good news for firms that make pharmaceutical ingredients according to a European chemical...

Japan to be hot destination for trials in 2015 say experts, despite drop in MRCTs last year

Japan to be hot destination for trials in 2015 say experts, despite drop in MRCTs last year

Japan was involved in fewer drug industry-sponsored multi-regional clinical trials (MRCT) in 2014 than any year since...

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...